FDA Inspection 1215196 — Sreenivasa R. Chandana, M.D., Ph.D.
The FDA completed an inspection of Sreenivasa R. Chandana, M.D., Ph.D. on August 11, 2023 in Grand Rapids, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 11, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Grand Rapids, MI (United States)
Additional Details
Clinical Investigator (CI)